
A large Australian university with major pharmaceutical research and campuses across several countries.
Monash is one of Australia's largest universities, with particular strength in pharmaceutical sciences, engineering, and medicine.
It operates campuses in Malaysia, Indonesia, and Italy alongside its Australian sites, giving it an unusually international footprint.
Melbourne's ecosystem combines medical technology, biotechnology, and enterprise software with a substantial professional services base.
Victoria's state government has invested heavily in medical research infrastructure, which supports a dense biomedical cluster.
Company formation clusters in drug delivery and pharmaceuticals, medical devices, additive manufacturing, and health software.
Its pharmaceutical sciences faculty is among the strongest in the region and a consistent source of licensing.
Melbourne hosts health-focused venture funds and state medical research funding.
Australian research and development tax incentives materially support early-stage research-based companies.
GCN’s global network includes millions of startups and founders and a broad community of investors, creating opportunities to discover potential connections across university communities.
.png)




